Principal Financial Group Inc United Therapeutics Corp Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q4 2024

A detailed history of Principal Financial Group Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 111,552 shares of UTHR stock, worth $39.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
111,552
Holding current value
$39.2 Million
% of portfolio
0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$348.66 - $410.0 $38.9 Million - $45.7 Million
111,552 New
111,552 $39.4 Million
Q3 2024

Oct 31, 2024
SELL
$311.04 - $363.55 $13.9 Million - $16.2 Million
-44,683 Reduced 28.43%
112,473 $40.3 Million
Q2 2024

Jul 29, 2024
SELL
$228.26 - $319.04 $5.9 Million - $8.24 Million
-25,835 Reduced 14.12%
157,156 $50.1 Million
Q1 2024

Apr 29, 2024
BUY
$210.76 - $249.51 $981,087 - $1.16 Million
4,655 Added 2.61%
182,991 $42 Million
Q4 2023

Feb 07, 2024
SELL
$214.88 - $256.94 $131,936 - $157,761
-614 Reduced 0.34%
178,336 $39.2 Million
Q3 2023

Nov 02, 2023
SELL
$211.82 - $248.24 $576,574 - $675,709
-2,722 Reduced 1.5%
178,950 $40.4 Million
Q2 2023

Aug 07, 2023
BUY
$205.19 - $232.99 $275,159 - $312,439
1,341 Added 0.74%
181,672 $40.1 Million
Q1 2023

May 09, 2023
SELL
$212.99 - $276.17 $24 Million - $31.2 Million
-112,916 Reduced 38.51%
180,331 $40.4 Million
Q4 2022

Feb 09, 2023
BUY
$205.95 - $280.43 $23.5 Million - $32 Million
114,114 Added 63.7%
293,247 $81.5 Million
Q3 2022

Nov 09, 2022
SELL
$203.3 - $244.17 $22.8 Million - $27.4 Million
-112,086 Reduced 38.49%
179,133 $37.5 Million
Q2 2022

Aug 10, 2022
BUY
$174.81 - $241.14 $24.2 Million - $33.3 Million
138,171 Added 90.28%
291,219 $68.6 Million
Q1 2022

May 09, 2022
BUY
$166.16 - $213.96 $10,966 - $14,121
66 Added 0.04%
153,048 $27.5 Million
Q4 2021

Feb 09, 2022
SELL
$184.32 - $216.08 $394,444 - $462,411
-2,140 Reduced 1.38%
152,982 $33.1 Million
Q3 2021

Nov 09, 2021
SELL
$179.86 - $214.88 $114,570 - $136,878
-637 Reduced 0.41%
155,122 $28.6 Million
Q2 2021

Aug 10, 2021
BUY
$170.47 - $211.93 $457,711 - $569,032
2,685 Added 1.75%
155,759 $27.9 Million
Q1 2021

May 10, 2021
BUY
$153.94 - $174.85 $3.31 Million - $3.76 Million
21,527 Added 16.36%
153,074 $25.6 Million
Q4 2020

Feb 08, 2021
SELL
$101.87 - $151.79 $47,267 - $70,430
-464 Reduced 0.35%
131,547 $20 Million
Q3 2020

Nov 06, 2020
SELL
$99.9 - $121.13 $366,233 - $444,062
-3,666 Reduced 2.7%
132,011 $13.3 Million
Q2 2020

Aug 05, 2020
SELL
$92.74 - $125.82 $2.89 Million - $3.92 Million
-31,141 Reduced 18.67%
135,677 $16.4 Million
Q1 2020

May 12, 2020
SELL
$79.39 - $115.35 $4.39 Million - $6.38 Million
-55,271 Reduced 24.89%
166,818 $15.8 Million
Q4 2019

Feb 05, 2020
BUY
$78.31 - $95.34 $2.52 Million - $3.07 Million
32,242 Added 16.98%
222,089 $19.6 Million
Q3 2019

Nov 13, 2019
SELL
$74.85 - $85.99 $245,657 - $282,219
-3,282 Reduced 1.7%
189,847 $15.1 Million
Q2 2019

Aug 12, 2019
BUY
$76.06 - $120.81 $29,359 - $46,632
386 Added 0.2%
193,129 $15.1 Million
Q1 2019

May 10, 2019
BUY
$107.15 - $126.84 $184,726 - $218,672
1,724 Added 0.9%
192,743 $22.6 Million
Q4 2018

Feb 14, 2019
SELL
$101.4 - $128.73 $303,084 - $384,773
-2,989 Reduced 1.54%
191,019 $20.8 Million
Q3 2018

Nov 14, 2018
BUY
$113.81 - $129.46 $242,870 - $276,267
2,134 Added 1.11%
194,008 $24.8 Million
Q2 2018

Aug 13, 2018
SELL
$101.14 - $118.31 $440,869 - $515,713
-4,359 Reduced 2.22%
191,874 $0
Q1 2018

May 14, 2018
BUY
$107.21 - $151.94 $578,505 - $819,868
5,396 Added 2.83%
196,233 $22 Million
Q4 2017

Feb 13, 2018
BUY
$118.58 - $151.28 $722,863 - $922,202
6,096 Added 3.3%
190,837 $28.2 Million
Q3 2017

Nov 02, 2017
BUY
$114.6 - $136.81 $21.2 Million - $25.3 Million
184,741
184,741 $21.7 Million

Others Institutions Holding UTHR

# of Institutions
681
Shares Held
42.2M
Call Options Held
194K
Put Options Held
298K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email